144 related articles for article (PubMed ID: 23978023)
1. [Prognostic significance of the NPM-ALK fusion gene in bone marrow and peripheral blood for patients with anaplastic large cell lymphoma].
Yang J; Zhao XX; Jin L; Duan YL; Huang S; Zhang M; Zhang R; Zhou CJ; Zhang YH
Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):700-3. PubMed ID: 23978023
[TBL] [Abstract][Full Text] [Related]
2. Quantitative PCR detection of NPM/ALK fusion gene and CD30 gene expression in patients with anaplastic large cell lymphoma--residual disease monitoring and a correlation with the disease status.
Kalinova M; Krskova L; Brizova H; Kabickova E; Kepak T; Kodet R
Leuk Res; 2008 Jan; 32(1):25-32. PubMed ID: 17320171
[TBL] [Abstract][Full Text] [Related]
3. Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis.
Mussolin L; Damm-Welk C; Pillon M; Zimmermann M; Franceschetto G; Pulford K; Reiter A; Rosolen A; Woessmann W
Leukemia; 2013 Feb; 27(2):416-22. PubMed ID: 22907048
[TBL] [Abstract][Full Text] [Related]
4. Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma.
Bohling SD; Jenson SD; Crockett DK; Schumacher JA; Elenitoba-Johnson KS; Lim MS
Leuk Res; 2008 Mar; 32(3):383-93. PubMed ID: 17720243
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and clinical implications of bone marrow involvement in pediatric anaplastic large cell lymphoma.
Mussolin L; Pillon M; d'Amore ES; Santoro N; Lombardi A; Fagioli F; Zanesco L; Rosolen A
Leukemia; 2005 Sep; 19(9):1643-7. PubMed ID: 16049513
[TBL] [Abstract][Full Text] [Related]
6. Mapping of genomic t(2;5)(p23;q35) break points in patients with anaplastic large cell lymphoma by sequencing long-range PCR products.
Luthra R; Pugh WC; Waasdorp M; Morris W; Cabanillas F; Chan PK; Sarris AH
Hematopathol Mol Hematol; 1998; 11(3-4):173-83. PubMed ID: 9844824
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric detection of circulating tumour cells in nucleophosmin/anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: comparison with quantitative polymerase chain reaction.
Damm-Welk C; Schieferstein J; Schwalm S; Reiter A; Woessmann W
Br J Haematol; 2007 Aug; 138(4):459-66. PubMed ID: 17608768
[TBL] [Abstract][Full Text] [Related]
8. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease.
Eyre TA; Khan D; Hall GW; Collins GP
Eur J Haematol; 2014 Dec; 93(6):455-68. PubMed ID: 24766435
[TBL] [Abstract][Full Text] [Related]
9. Extra copies of ALK gene locus is a recurrent genetic aberration and favorable prognostic factor in both ALK-positive and ALK-negative anaplastic large cell lymphomas.
Yu R; Chen G; Zhou C; Gao Z; Shi Y; Shi Y; Zhou X; Xie J; Liu H; Gong L
Leuk Res; 2012 Sep; 36(9):1141-6. PubMed ID: 22726922
[TBL] [Abstract][Full Text] [Related]
10. The t(2;5) in human lymphomas.
Kadin ME; Morris SW
Leuk Lymphoma; 1998 Apr; 29(3-4):249-56. PubMed ID: 9684923
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of circulating tumor cells in bone marrow or peripheral blood as detected by qualitative and quantitative PCR in pediatric NPM-ALK-positive anaplastic large-cell lymphoma.
Damm-Welk C; Busch K; Burkhardt B; Schieferstein J; Viehmann S; Oschlies I; Klapper W; Zimmermann M; Harbott J; Reiter A; Woessmann W
Blood; 2007 Jul; 110(2):670-7. PubMed ID: 17392503
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow involvement in NPM-ALK-positive lymphoma: report of two cases.
Sadahira Y; Hata S; Sugihara T; Manabe T
Pathol Res Pract; 1999; 195(9):657-61. PubMed ID: 10507087
[TBL] [Abstract][Full Text] [Related]
13. Molecular variant of the NPM-ALK rearrangement of Ki-1 lymphoma involving a cryptic ALK splice site.
Ladanyi M; Cavalchire G
Genes Chromosomes Cancer; 1996 Mar; 15(3):173-7. PubMed ID: 8721682
[TBL] [Abstract][Full Text] [Related]
14. ALK-negative anaplastic large cell lymphoma with extensive peripheral blood and bone marrow involvements manifested as "leukemic phase".
Lu Y; Zhao X; Wang E; Chen W; Huang Q
Leuk Res; 2010 Apr; 34(4):475-82. PubMed ID: 19695703
[TBL] [Abstract][Full Text] [Related]
15. ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35).
Colleoni GW; Bridge JA; Garicochea B; Liu J; Filippa DA; Ladanyi M
Am J Pathol; 2000 Mar; 156(3):781-9. PubMed ID: 10702393
[TBL] [Abstract][Full Text] [Related]
16. The NPM/ALK gene fusion in the pathogenesis of anaplastic large cell lymphoma.
Ladanyi M
Cancer Surv; 1997; 30():59-75. PubMed ID: 9547986
[TBL] [Abstract][Full Text] [Related]
17. Analysis of nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-reactive CD8(+) T cell responses in children with NPM-ALK(+) anaplastic large cell lymphoma.
K Singh V; Werner S; Hackstein H; Lennerz V; Reiter A; Wölfel T; Damm-Welk C; Woessmann W
Clin Exp Immunol; 2016 Oct; 186(1):96-105. PubMed ID: 27414060
[TBL] [Abstract][Full Text] [Related]
18. The heat shock protein-90 co-chaperone, Cyclophilin 40, promotes ALK-positive, anaplastic large cell lymphoma viability and its expression is regulated by the NPM-ALK oncoprotein.
Pearson JD; Mohammed Z; Bacani JT; Lai R; Ingham RJ
BMC Cancer; 2012 Jun; 12():229. PubMed ID: 22681779
[TBL] [Abstract][Full Text] [Related]
19. The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner.
Hsu FY; Johnston PB; Burke KA; Zhao Y
Cancer Res; 2006 Sep; 66(18):9002-8. PubMed ID: 16982741
[TBL] [Abstract][Full Text] [Related]
20. Expression of ALK protein, mRNA and fusion transcripts in anaplastic large cell lymphoma.
Huang W; Li X; Yao X; Lu Y; Li B; Sheng W; Lu H; Jin A; Zhou X
Exp Mol Pathol; 2009 Apr; 86(2):121-6. PubMed ID: 19135051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
